PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 13, 2022SHILAP Revista de lepidopterología152 citationsOpen Access

Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications

View Full Paper
MHMarco HeestermansGPGéraldine PoénouHHHind Hamzeh‐Cognasse

Structured PICO

I
Intervention
Anticoagulants

This review provides a comprehensive overview of the history, mechanisms, pharmacology, and indications of currently prescribed anticoagulants for venous thromboembolism.

Abstract

Anticoagulant drugs antagonize coagulation and are used to prevent or cure (recurrent) venous thromboembolism (VTE). Drugs to prevent clotting have been used for more than a century, and, nowadays, physicians possess a broad panel of multiple anticoagulants to meet the individual needs of a patient. Within this review, we aimed to revise the history of the different anticoagulants that are currently prescribed in the clinic. In addition, we compared their pharmacological properties, medical indications, and the difficulties in implementing new anticoagulants in vulnerable patient populations. Since the introduction of unfractionated heparin in the 1930s, major advances in the mechanistic understanding and the medical use of anticoagulants have allowed for significant improvements to treat VTE patients. However, a new generation of anticoagulants is currently being tested in clinical trials, with the goal of further optimizing medical care.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Heestermans et al. (2022) studied this question.

synapsesocial.com/papers/69dd46a67d97b7e86940c83chttps://doi.org/10.3390/cells11203214
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacokinetic Drug Interaction Studies with Enzalutamide2015 · 161 citations
  2. 2Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis1968 · 276 citations
  3. 3Dissociation of hospitalization and mortality trends for myocardial infarction in the United States from 1988 to 19972002 · 36 citations
  4. 4Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum2019 · 317 citations
  5. 5The amino acid sequence of antistasin. A potent inhibitor of factor Xa reveals a repeated internal structure.1988 · 112 citations